REQUEST A DEMO
Total
USD $0.00
Search more companies

Setaa - Pharma-ecuador S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
Full name: Setaa - Pharma-ecuador S.A. Profile Updated: May 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Setaa - Pharma-ecuador S.A. is based in Ecuador, with the head office in Quito. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was incorporated on August 21, 2017. The total number of employees is currently 1 (2023). Its’ total assets recorded a growth of 123.88%.

Headquarters
Orellana E11-28, Orellana Bldg. , Floor 501
Quito; Pichincha;

Contact Details: Purchase the Setaa - Pharma-ecuador S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Setaa - Pharma-ecuador S.A. report to view the information.
Outstanding Shares:
Purchase the Setaa - Pharma-ecuador S.A. report to view the information.
Registered Capital:
Purchase the Setaa - Pharma-ecuador S.A. report to view the information.
Incorporation Date:
August 21, 2017
Key Executives
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
95%
Purchase this report to view the information.
5%
Company Performance
Financial values in the chart are available after Setaa - Pharma-ecuador S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
71.63%
Net Profit (Loss) for the Period
55.34%
Total assets
123.88%
Total equity
-18.52%
Return on Equity (ROE)
-25.84%
Debt to Equity Ratio
38.82%
Quick Ratio
0.24%
Cash Ratio
-0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?